Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? Yes
Write-up: This case was reported by a healthcare professional (subject) via a sales representative and described the occurrence of post menopausal bleeding in an adult female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included menopausal 4 years ago. On 23 October 2009 the subject received unspecified dose of CERVARIX (unknown route). Lot number not provided. On 23 October 2009, less than one day after vaccination with CERVARIX, the subject experienced cold feeling, injection site pain and joint pain. These events lasted one day. On 24 October 2009, the events were resolved. On 24 October 2009, one day after vaccination with CERVARIX, the subject experienced post menopausal bleeding. The healthcare professional considered the events were life threatening. The subject was treated with BRUFEN. On 30 October 2009, the post menopausal bleeding was resolved. The healthcare professional considered the events were almost certainly related to vaccination with CERVARIX.
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166